Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.32%11.48M | 32.12%15.47M | -24.44%48.01M | 40.25%18.43M | -46.82%8.16M | -40.15%10.04M | -35.98%11.71M | -15.77%63.55M | -23.50%13.14M | -10.95%15.34M |
| Cost of revenue | -24.58%10.01M | 0.15%14.34M | 36.55%92.15M | 254.57%49.57M | -14.84%14.97M | -21.69%13.28M | -23.84%14.31M | -11.53%67.49M | -29.54%13.98M | 3.53%17.58M |
| Gross profit | 145.35%1.47M | 143.42%1.13M | -1,020.23%-44.14M | -3,606.90%-31.14M | -204.11%-6.82M | -1,727.68%-3.24M | -414.20%-2.61M | -371.86%-3.94M | 68.46%-840K | -1,010.98%-2.24M |
| Operating expense | 35.07%4.37M | 8.91%3.28M | 125.57%12.74M | -27.43%3.02M | 105.50%3.15M | 45.77%3.24M | 58.32%3.01M | -679.10%-49.81M | 133.40%4.16M | -2,903.13%-57.24M |
| Selling and administrative expenses | 39.79%4.63M | 18.86%3.84M | -39.74%20.49M | 157.87%10.34M | -87.25%3.47M | 45.81%3.31M | 53.98%3.23M | 289.17%34M | 64.99%4.01M | 1,194.34%27.19M |
| -Selling and marketing expense | -38.96%224K | -48.21%217K | -10.90%1.26M | -40.22%214K | -20.44%358K | 5.46%367K | 63.04%419K | 7.45%1.41M | 27.86%358K | 54.64%450K |
| -General and administrative expense | 49.61%4.4M | 28.86%3.62M | -41.00%19.23M | 177.28%10.13M | -88.38%3.11M | 53.12%2.94M | 52.72%2.81M | 339.09%32.59M | 69.83%3.65M | 1,377.57%26.74M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --152K | ---- |
| Total other operating income | 245.95%256K | 154.30%562K | -90.75%7.75M | 800.67%7.32M | -99.63%316K | 48.00%74K | 12.18%221K | 453.93%83.81M | -107.02%-1.05M | 143,008.47%84.43M |
| Operating profit | 55.12%-2.9M | 61.82%-2.14M | -224.00%-56.88M | -582.77%-34.16M | -118.12%-9.97M | -169.96%-6.47M | -133.28%-5.62M | 725.26%45.87M | -151.04%-5M | 3,162.31%55M |
| Net non-operating interest income (expenses) | -71.53%-247K | -55.73%-299K | 79.41%-232K | 1.97%-299K | 58.60%-154K | 79.43%-144K | 70.19%-192K | 48.73%-1.13M | 41.12%-305K | 39.81%-372K |
| Non-operating interest income | ---- | ---- | -37.63%557K | ---- | ---- | ---- | ---- | 726.85%893K | ---- | ---- |
| Non-operating interest expense | 71.53%247K | 55.73%299K | -60.94%789K | -1.97%299K | -58.60%154K | -79.43%144K | -70.19%192K | -12.40%2.02M | -51.28%305K | -39.81%372K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 101.34%21K | -12,176.92%-1.57M | ||||||||
| Less:Write off | ---- | ---- | -101.34%-21K | ---- | ---- | ---- | ---- | 12,176.92%1.57M | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 52.37%-3.15M | 57.93%-2.44M | -232.23%-57.09M | -549.17%-34.46M | -118.52%-10.12M | -113.59%-6.62M | -90.33%-5.81M | 1,179.90%43.17M | -157.09%-5.31M | 2,362.92%54.63M |
| Income tax | 105.56%2K | 1,035.00%454K | 11.39%-249K | 52.63%-162K | -108.77%-5K | -1,000.00%-36K | 40K | -118.49%-281K | -122.69%-342K | 5,800.00%57K |
| Net income | 52.07%-3.15M | 50.45%-2.9M | -230.80%-56.84M | -590.62%-34.3M | -118.53%-10.11M | -112.16%-6.58M | -91.64%-5.85M | 2,244.95%43.45M | -163.75%-4.97M | 2,361.50%54.57M |
| Net income continuous operations | 52.07%-3.15M | 50.45%-2.9M | -230.80%-56.84M | -590.62%-34.3M | -118.53%-10.11M | -112.16%-6.58M | -91.64%-5.85M | 2,244.95%43.45M | -163.75%-4.97M | 2,361.50%54.57M |
| Noncontrolling interests | 24.17%-229K | 178.95%15K | -106.15%-1.67M | -4,600.00%-1.18M | -100.62%-176K | 52.14%-302K | 97.25%-19K | 1,866.64%27.17M | 94.15%-25K | 5,034.08%28.52M |
| Net income attributable to the company | 53.42%-2.92M | 50.03%-2.91M | -438.83%-55.17M | -570.33%-33.12M | -138.15%-9.94M | -154.13%-6.28M | -147.05%-5.83M | 380.12%16.28M | -160.13%-4.94M | 1,519.67%26.05M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 53.42%-2.92M | 50.03%-2.91M | -438.83%-55.17M | -570.33%-33.12M | -138.15%-9.94M | -154.13%-6.28M | -147.05%-5.83M | 380.12%16.28M | -160.13%-4.94M | 1,519.67%26.05M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 57.54%-0.0259 | 54.50%-0.0258 | -431.71%-0.5251 | -555.51%-0.3153 | -138.14%-0.0966 | -154.17%-0.061 | -147.60%-0.0567 | 379.70%0.1583 | -160.20%-0.0481 | 1,523.03%0.2533 |
| Diluted earnings per share | 57.54%-0.0259 | 54.50%-0.0258 | -431.71%-0.5251 | -555.51%-0.3153 | -138.14%-0.0966 | -154.17%-0.061 | -147.60%-0.0567 | 379.70%0.1583 | -160.20%-0.0481 | 1,523.03%0.2533 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.